Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

This study has been terminated.
(Low accrual)
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00481845
First received: May 31, 2007
Last updated: March 3, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)